Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic radiation myelitis.

R H Fitzgerald, R D Marks, K M Wallace

    Radiology
    |August 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Split-course accelerated fractionation for lung cancer showed a 22.5% survival rate over 11 months, but 13.3% of survivors developed progressive myelitis. This review examines the technique and myelitis risk factors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Post-discharge prevention of deep vein thrombosis following total joint replacement.

    Orthopedics·2014
    Same author

    Managing the risk of venous thromboembolism in orthopedics: introductory remarks.

    Orthopedics·2014
    Same author

    Preventing dvt following total knee replacement: a review of recent clinical trials.

    Orthopedics·2014
    Same author

    Stable transformation of Phaseolus vulgaris via electric-discharge mediated particle acceleration.

    Plant cell reports·2013
    Same author

    Secondary osteomyelitis.

    Canadian Medical Association journal·2010
    Same author

    Laundering protocols for chlorpyrifos residue removal from pest control operators' overalls.

    Bulletin of environmental contamination and toxicology·2005
    Same journal

    Erratum for: Prediction of Lobar Emphysema Progression with a CT-Based Foundational Model.

    Radiology·2026
    Same journal

    Erratum for: Associations of MRI-derived Paraspinal IMAT and LMM with Cardiometabolic Risk Factors: Results from a German Cohort.

    Radiology·2026
    Same journal

    Erratum for: Blue Rubber Bleb Nevus Syndrome.

    Radiology·2026
    Same journal

    Redefining the Clinical Role of MRI in Endometrial Cancer Staging.

    Radiology·2026
    Same journal

    To Ablate or Not to Ablate: The Colorectal Liver Metastasis Question.

    Radiology·2026
    Same journal

    The Limits of Radiologic Categorization in Pulmonary Nonsolid Nodules.

    Radiology·2026
    See all related articles

    Area of Science:

    • Oncology
    • Radiation Oncology
    • Neurology

    Background:

    • Split-course accelerated fractionation was used for primary bronchogenic carcinoma treatment.
    • This technique involves delivering 4,000 rad (40 Gy) over a specific period.
    • Concerns exist regarding the resurgence of rapid fractionation methods in cancer treatment.

    Purpose of the Study:

    • To review the authors' experience with split-course accelerated fractionation for lung cancer.
    • To analyze the incidence of progressive myelitis following this radiation therapy.
    • To discuss current understanding of factors influencing radiation-induced myelitis.

    Main Methods:

    • Retrospective analysis of 200 patients with primary bronchogenic carcinoma treated between March 1971 and September 1973.

    Related Experiment Videos

  • Radiation dose administered was 4,000 rad (40 Gy) using split-course accelerated fractionation.
  • Patient outcomes, including survival and development of myelitis, were recorded.

    • Main Results:

    • 45 patients (22.5%) survived for more than 11 months.
    • Among the long-term survivors, 6 patients (13.3%) developed progressive myelitis.
    • The study highlights a significant complication rate associated with this fractionation schedule.

    Conclusions:

    • Split-course accelerated fractionation for lung cancer presents a trade-off between survival benefit and the risk of myelitis.
    • Further investigation into risk factors and mitigation strategies for radiation myelitis is warranted.
    • Understanding the factors affecting radiation myelitis is crucial for optimizing treatment protocols.